In 2024, the sale of antidepressant drugs in Russia increased by 20%, reaching 16.1 million packages by November, according ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

Advancements and Projections in the Global Pain Management Therapeutics Market: Insights, Trends, Opportunities, and Recent ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

Authoritative and well-researched, Chemically Imbalanced documents the overinflation of antidepressant efficacy, where the ...

The company said that the nasal spray is a ketamine-derived drug, first approved in 2019, to be used in combination with ...

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major ...

As you start weaning off your antidepressant, tell your doctor about any changes in your mood and energy levels and any new symptoms you experience. That way, they can adjust the plan as needed.

In her new memoir, Shields recalled an interview in which Cruise “disparaged” her in a "ridiculous rant" during his ...

Alembic Pharmaceuticals has received final approval from the USFDA for its generic version of Brexpiprazole tablets, used in ...